Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-797576ffbb-jhnrh Total loading time: 0 Render date: 2023-12-05T14:10:57.941Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "useRatesEcommerce": true } hasContentIssue false

N

from Section 1 - Diagnostics

Published online by Cambridge University Press:  30 May 2019

Edited by
Alan B. Ettinger ,
Deborah M. Weisbrot  and
Casey E. Gallimore
Alan B. Ettinger
Affiliation:
Safe Passage Diagnostics, New York
Deborah M. Weisbrot
Affiliation:
State University of New York, Stony Brook
Casey E. Gallimore
Affiliation:
University of Wisconsin
Get access
Type
Chapter
Information
Synopsis of Neurology, Psychiatry and Related Systemic Disorders , pp. 404 - 424
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Fassone, E, Shamima, R. REVIEW Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet. 2012; 49: 578–90.CrossRefGoogle ScholarPubMed
Gorman, GS, Schaefer, AM, Ng, Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015; 77(5): 753–9. DOI: 10.1002/ana.24362.CrossRefGoogle ScholarPubMed
Lightowlers, RN, Taylor, RW, Turnbull, DM. Mutations causing mitochondrial disease: What is new and what challenges remain? Science. 2015; 349(6255): 1494–9. DOI: 10.1126/science.aac7516.CrossRefGoogle ScholarPubMed
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.Google Scholar
Andlauer, O, Moore, IVH, Hong, SC, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep. 2012; 35: 1247–55.CrossRefGoogle ScholarPubMed
Dauvilliers, Y, Arnulf, I, Mignot, E. Narcolepsy with cataplexy. Lancet. 2007; 369: 499–511.CrossRefGoogle ScholarPubMed
Wang, J, Greenberg, H. Status cataplecticus precipitated by abrupt withdrawal of venlafaxine. J Clin Sleep Med. 2013; 9(7): 715–6.Google ScholarPubMed
Zeman, A, Britton, T, Douglas, N, et al. Narcolepsy and excessive daytime sleepiness. BMJ. 2004; 329: 724.CrossRefGoogle ScholarPubMed
American Cancer Society. What are the key statistics about nasopharyngeal cancer? Updated Aug 8, 2016. Available from https://www.cancer.org/cancer/nasopharyngeal-cancer/about/key-statistics.html. Accessed Sep 9, 2018.Google Scholar
Rosenbaum, HE, Seaman, WB. Neurologic manifestations of nasopharyngeal tumors. Neurology. 1955; 5(12): 868–74.CrossRefGoogle ScholarPubMed
Turgman, J, Braham, J, Modan, B, Goldhammer, Y. Neurological complications in patients with malignant tumors of the nasopharynx. Eur Neurol. 1978; 17(3): 149–54.CrossRefGoogle ScholarPubMed
Clouston, PD, Sharpe, DM, Corbett, AJ, Kos, S, Kennedy, PJ. Perineural spread of cutaneous head and neck cancer. Its orbital and central neurologic complications. Arch Neurol. 1990; 47(1): 73–7.CrossRefGoogle ScholarPubMed
Heroiu Cataloiu, AD, Danciu, CE, Popescu, CR. Multiple cancers of the head and neck. Maedica (Buchar). 2013; 8(1): 80–5.Google ScholarPubMed
Ruzevick, J, Olivi, A, Westra, WH. Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancer. J Neurooncol. 2013; 112(3): 449–54.CrossRefGoogle ScholarPubMed
Brandtzaeg, P, Ovstebøo, R, Kierulf, P. Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis. 1992; 166: 650.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Meningococcal disease. Updated Apr 9, 2018. https://www.cdc.gov/meningococcal/index.html. Accessed Sep 9, 2018.Google Scholar
Heckenberg, SG, de Gans, J, Brouwer, MC, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore). 2008; 87: 185.CrossRefGoogle ScholarPubMed
Julayanont, P, Ruthirago, D, DeToledo, JC. Bacterial meningitis and neurological complications in adults. SWRCCC. 2016; 4(14): 5–16.Google Scholar
Ropper, A, Samuels, M. Disease of the peripheral nervous system. In Adams and Victor's principles of neurology. 9th ed. New York: McGraw-Hill Education/Medical; 2009.Google Scholar
Amato, AA, Russell, JA. Neuromuscular disorders. New York: McGraw-Hill; 2008. pp. 578, 582–583.Google Scholar
Mah, JK, Joseph, JT. An overview of congenital myopathies. Continuum (Minneap Minn). 2016; 22(6): 1932–53.Google ScholarPubMed
Jung, HH, Danek, A, Walker, RH. Neuroacanthocytosis syndromes. Orphanet J Rare Dis. 2011; 6: 68.CrossRefGoogle ScholarPubMed
Walker, RH. Untangling the thorns: advances in the neuroacanthocytosis syndromes. J Mov Disord. 2015; 8: 41–54.CrossRefGoogle ScholarPubMed
Walker, RH, Jung, HH, Danek, A. Neuroacanthocytosis. Handb Clin Neurol. 2011; 100: 141–51.CrossRefGoogle ScholarPubMed
Lee, J, Hegele, RA. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. J Inherit Metab Dis. 2014; 37: 333–9.CrossRefGoogle ScholarPubMed
Chinnery, PF. Neuroferritinopathy. Apr 25, 2005. Updated Dec 23, 2010. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2016. Available from: www.ncbi.nlm.nih.gov/books/NBK1141/. Accessed Aug 30, 2018.Google Scholar
Crompton, DE, Chinnery, PF, Bates, D, et al. Spectrum of movement disorders in neuroferritinopathy. Mov Disord. 2005; 20: 95–9.CrossRefGoogle ScholarPubMed
McNeill, A, Birchall, D, Hayflick, SJ, et al. T2 and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. 2008; 70: 1614–9.CrossRefGoogle ScholarPubMed
OMIM. Neurodegeneration with brain iron accumulation 3; NBIA3 (606159). https://www.omim.org/entry/606159. Accessed Sep 9, 2018.Google Scholar
Wills, AJ, Sawle, GV, Guilbert, PR, Curtis, AR. Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry. 2002; 73: 91–2.CrossRefGoogle ScholarPubMed
Batista, PB, Bertollo, EM, de Souza, Costa D, et al. Neurofibromatosis: part 2 – clinical management. Arq Neuropsiquiatr. 2015; 73(6): 531–43.CrossRefGoogle ScholarPubMed
Fox, CJ, Tomajian, S, Kaye, AJ, et al. Perioperative management of neurofibromatosis type 1. Ochsner J. 2012; 12(2): 111–21.Google ScholarPubMed
Pastar, Z, Lipozencić, J, Budimcić, D, Tomljanović-veselski, M. Neurofibromatosis: review of the literature and case report. Acta Dermatovenerol Croat. 2006; 14(3): 167–71.Google ScholarPubMed
Asthagiri, AR, Parry, DM, Butman, JA, et al. Neurofibromatosis type 2. Lancet. 2009; 373(9679): 1974–86.CrossRefGoogle ScholarPubMed
Mathieu, D, Kondziolka, D, Flickinger, JC, et al. Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery. 2007; 60(3): 460–8.CrossRefGoogle ScholarPubMed
Pastar, Z, Lipozencić, J, Budimcić, D, Tomljanović-Veselski, M. Neurofibromatosis: review of the literature and case report. Acta Dermatovenerol Croat. 2006; 14(3): 167–71.Google ScholarPubMed
Bick, A, Meiner, Z, Gotkine, M, Levin, N. Using advanced methods to study neurolathyrism. IMAJ. 2016; 18: 341–5.Google ScholarPubMed
Ngudi, D. Research on motor neuron diseases konzo and neurolathyrism: trends from 1990 to 2010. PloS Negl Trop Dis. 2012; 6(7): 11759.CrossRefGoogle ScholarPubMed
Tan, RY, Xing, G-Y, Zhou, G-M, et al. Toxin β-ODAP activates integrin β1 and focal adhesion: A critical pathway to cause neurolathyrism. Sci Rep. 2017; 7: 40677.CrossRefGoogle ScholarPubMed
Asgari, N, Lillevang, ST, Skejoe, HP, et al. A population-based study of neuromyelitis optica in Caucasians. Neurology. 2011; 76: 1589.CrossRefGoogle ScholarPubMed
Cabrera-Gómez, JA, Kurtzke, JF, González-Quevedo, A, Lara-Rodríguez, R. An epidemiological study of neuromyelitis optica in Cuba. J Neurol. 2009; 256: 35.CrossRefGoogle ScholarPubMed
Crout, T, Parks, LP, Majithia, V. Neuromyelitis optica (Devic's syndrome): an appraisal. Curr Rheumatol Rep. 1999; 18(8): 54.Google Scholar
Flanagan, EP, Cabre, P, Weinshenker, BG, et al. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016; Feb 17. DOI: 10.1002/ana.24617. [Epub ahead of print]CrossRefGoogle ScholarPubMed
Jung, JS, Bhat, RV, Preston, GM, et al. Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci USA. 1994; 91: 13052.CrossRefGoogle ScholarPubMed
Mealy, MA, Wingerchuk, DM, Greenberg, BM, Levy, M. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol. 2012; 69: 1176.CrossRefGoogle ScholarPubMed
Papais-Alvarenga, RM, Carellos, SC, Alvarenga, MP, et al. Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol. 2008; 126: 12.CrossRefGoogle ScholarPubMed
Sellner, J, Boggild, M, Clanet, M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010; 17: 1019.CrossRefGoogle ScholarPubMed
Uzawa, A, Mori, M, Kuwabara, S. Neuromyelitis optica: concept, immunology and treatment. J Clin Neurosci. 2014; 21: 12.CrossRefGoogle ScholarPubMed
Wingerchuk, DM. Neuromyelitis optica: effect of gender. J Neurol Sci. 2009; 286: 18.CrossRefGoogle ScholarPubMed
Amato, AA, Russell, JA. Neuromuscular disorders. New York: McGraw-Hill; 2008. pp. 144–56.Google Scholar
Cugati, S, Varma, DD, Chen, CS, Lee, AW. Treatment options for central retinal artery occlusion. Curr Treat Options Neurol. 2013; 15(1): 63–77.CrossRefGoogle ScholarPubMed
Digre, KB. Neuro-ophthalmology and pregnancy: what does a neuro-ophthalmologist need to know? J Neuroophthalmol. 2011; 31(4): 381–7.CrossRefGoogle ScholarPubMed
Errera, M, Kohly, RP, da Cruz, L. Pregnancy-associated retinal diseases and their management. Surv Ophthalmol. 2013; 58(2): 127–42.CrossRefGoogle ScholarPubMed
Grant, AD, Chung, SM. The eye in pregnancy: ophthalmologic and neuro-ophthalmologic changes. Clin Obstet Gynecol. 2013; 56(2): 397–412.CrossRefGoogle ScholarPubMed
Bradshaw, AD, Advincula, AP. Postoperative neuropathy in gynecologic surgery. Obstet Gynecol Clin North Am. 2010; 37(3): 451–9.CrossRefGoogle ScholarPubMed
Padua, L, Aprile, I, Caliandro, P, et al.; Italian CTS Study Group. Carpal tunnel syndrome in pregnancy. Neurology. 2002; 59(10): 1643–6.CrossRefGoogle ScholarPubMed
Sax, TW, Rosenbaum, RB. Neuromuscular disorders in pregnancy. Muscle Nerve. 2006; 34: 559–71.CrossRefGoogle ScholarPubMed
Yoram, C, Lavie, O, Granovsky-Grisaru, S, Aboulafia, Y, Diamant, YZ. Bell palsy complicating pregnancy. Obs Gyn Survey. 2000; 55(3): 184–8.Google Scholar
Katirji, B, Kaminski, HJ, Ruff, RL. Neuromuscular disorders in clinical practice. 2nd ed. New York: Springer-Verlag New York; 2014.Google Scholar
Campagnolo, M, et al. Polyneuropathy with anti-sulfatide and anti-MAG antibodies: Clinical, neurophysiological, pathologic features and response to treatment. J Neuroimmunol. 2015; 281: 1–4.CrossRefGoogle Scholar
Neuromuscular Disease Center. Anti-sulfatide antibodies in sensory-motor neuropathies. http://neuromuscular.wustl.edu/antibody/sulfatide.html. Accessed Aug 31, 2018.Google Scholar
Ropper, AH, Samuels, MA, Klein, JP. Adams and Victor's principles of neurology. 10th ed. New York: McGraw-Hill Education/Medical; 2014.Google Scholar
Kasper, DL, Fauci, AS, Hauser, SL, et al., eds. Harrison's principles of internal medicine. 19th ed. New York: McGraw-Hill Education/Medical; 2015.Google Scholar
Wan, P, Moat, S, Anstey, A. Pellagra: a review with emphasis on photosensitivity. Br J Dermatol. 2011; 164: 1188.CrossRefGoogle ScholarPubMed
Bomb, BS, Bedi, HK, Bhatnagar, LK. Post-ischaemic paresthesiae in pellagrins. J Neurol Neurosurg Psychiatry. 1977; 40: 265.CrossRefGoogle Scholar
Ishii, N, Nishihara, Y. Pellagra among chronic alcoholics: Clinical and pathological study of 20 necropsy cases. J Neurol Neurosurg Psychiatry. 1981; 44: 209.CrossRefGoogle ScholarPubMed
Jolliffe, N, Bowman, KM, Rosenblum, LA, Fein, HD. Nicotinic acid deficiency encephalopathy. JAMA. 1940; 114: 307.Google Scholar
Altschul, R, Hoffer, A, Stephen, JD. Influence of nicotinic acid on serum cholesterol in man. Arch Biochem Biophys. 1955; 54: 558.CrossRefGoogle ScholarPubMed
DiPalma, JR, Thayer, WS. Use of niacin as a drug. Annu Rev Nutr. 1991; 11: 169.CrossRefGoogle ScholarPubMed
Gharavi, AG, Diamond, JA, Smith, DA, Phillips, RA. Niacin-induced myopathy. Am J Cardiol. 1994; 74: 841.CrossRefGoogle ScholarPubMed
Vilter, RW, Mueller, JF, Bean, WB. The therapeutic effect of tryptophane in human pellagra. J Lab Clin Med. 1949; 34: 409.Google ScholarPubMed
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.Google Scholar
Hobson, JA, McCarley, RW. The brain as a dream state generator: an activation-synthesis hypothesis of the dream process. Am J Psychiatry. 1977; 134: 1335–48.Google ScholarPubMed
Krakow, B, Hollifield, M, Johnston, L, et al. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA. 2001; 286: 537–45.CrossRefGoogle ScholarPubMed
Nadorff, MR, Lambdin, KK, Germain, A. Pharmacological and non-pharmacological treatments for nightmare disorder. Int Rev Psychiatry. 2014; 26: 225–36.CrossRefGoogle ScholarPubMed
Nielsen, T, Zadra, A. Idiopathic nightmares and dream disturbances associated with sleep-wake transitions. In Kryger, MH, Roth, T, Dement, WC, eds. Principles and practice of sleep medicine. 5th ed. Philadelphia: Saunders; 2010. pp. 1106–15.Google Scholar
Becker, DE, Rosenberg, M. Nitrous oxide and the inhalation anesthetics. Anesth Progr. 2008; 55(4): 124–31. DOI: 10.2344/0003-3006-55.4.124.CrossRefGoogle ScholarPubMed
Drug Addiction Treatment. Health effects of nitric oxide abuse. www.drugaddictiontreatment.com/types-of-addiction/club-drugs/health-effects-of-nitrous-oxide-abuse/. Accessed Aug 31, 2018.Google Scholar
McCann, SM, Kimura, M, Karanth, S, Yu, WH, Rettori, V. Nitric oxide controls the hypothalamic-pituitary response to cytokines. Neuroimmunomodulation. 1997; 4: 98–106. DOI: 10.1159/000097327.CrossRefGoogle ScholarPubMed
Shoults, K. Case report: Neurologic complications of nitrous oxide abuse. BCMJ. 2016; 58(4): 192–4.Google Scholar
Anagnostou, T, Arvanitis, M, Kourkoumpetis, TK, et al. Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature. Medicine (Baltimore). 2014; 93(1): 19–32.Google ScholarPubMed
Brown-Elliott, BA, Brown, JM, Conville, PS, Wallace, RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006; 19: 259.CrossRefGoogle ScholarPubMed
Centers of Disease Control and Prevention. Nocardiosis. Updated Feb 24, 2017. https://www.cdc.gov/nocardiosis/. Accessed Aug 31, 2018.Google Scholar
Mamelak, AN, Obana, WG, Flaherty, JF, Rosenblum, ML. Nocardial brain abscess: treatment strategies and factors influencing outcome. Neurosurgery. 1994; 35: 622.Google ScholarPubMed
Johnson, LN, Guy, ME, Krohel, GB, Madsen, RW. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000; 107: 521–6.CrossRefGoogle ScholarPubMed
Levin, LA, Danesh-Meyer, HV. Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2008; 126: 1582–5.CrossRefGoogle ScholarPubMed
Miller, NR, ed. Anterior ischemic optic neuropathy. In Walsh and Hoyt's clinical neuro-ophthalmology. Vol 1. Baltimore: Williams & Wilkins; 1982. pp. 212–26.Google Scholar
Fernandez-Torre, JL, Kaplan, PW, Hernandez-Hernandez, MA. New understanding of nonconvulsive status epilepticus in adults: treatments and challenges. Expert Rev Neurother. 2015; 15(12): 1455–73.CrossRefGoogle ScholarPubMed
Meierkord, H, Holtkamp, M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol. 2007; 6(4): 329–39.CrossRefGoogle ScholarPubMed
Trinka, E, Cock, H, Hesdorffer, D, et al. A definition and classification of status epilepticus: Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015; 56(10): 1515–23.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×